MORGAN STANLEY

Read how Morgan Stanley’s 424(b)(2) prospectus disclosure clarifies its corporate structure, boosts transparency, and signals strong regulatory compliance for investors.

Explore Morgan Stanley’s 2026 SEC filings, Hong Kong IPO role, and growing Chinese stakes—why the firm’s disclosures matter for investors and regulators.

Explore Morgan Stanley’s new structured‑note range: S&P‑500‑based, principal‑protected, high‑participation rates, crafted for low‑yield environments and institutional alpha seekers.

Discover Morgan Stanley’s fully guaranteed market‑linked security, offering 18.75% fixed return with a 30% buffer on AMD & MSFT performance.

Explore Morgan Stanley’s new PAR‑structured products: leveraged equity and commodity notes with unconditional guarantees, designed for risk‑tolerant investors in a tightening regulatory landscape.

How Morgan Stanley’s market‑linked notes hide key risks and hidden costs, and why investors need clearer guarantees, fees, and liquidity details.

Morgan Stanley’s latest Q4 earnings show steady revenue, strong defence contracts, and a potential €650 M PSSB divestiture – key insights for investors.

Explore Morgan Stanley’s new Principal‑at‑Risk structured notes—multi‑benchmark exposure, contingent coupons, and early‑call features—with a clear risk overview and potential upside.

Explore Morgan Stanley’s latest SEC filings, structured product strategy, and new 5 % withdrawal cap on its $7 B private‑credit fund—insights into liquidity, risk, and investor impact.

Explore Morgan Stanley’s June 2026 Reg 424(b)(2) filing—insights into broker‑dealer compliance, ESG gaps, fintech prospects and hidden risks for investors.